Repros Therapeutics Inc. Board Nominates Dr. Stephen Howell to Its Board of Directors

THE WOODLANDS, Texas--(BUSINESS WIRE)--Repros Therapeutics Inc. (NasdaqGM:RPRX) today announces the nomination of Stephen B. Howell, M.D., Professor of Medicine at the University of California, San Diego, to its Board of Directors for election at its Annual Shareholders Meeting on May 20, 2009.

Back to news